Integrated Proteins Intrinsic Value
Integrated Proteins (INTEGFD) median intrinsic value is ₹43.15 from 6 valuation models (range ₹29–₹43), vs current price ₹143.85 — -70.0% downside (Trading Above Calculated Value), margin of safety -100.0%. Read INTEGFD dividend track record for the complete payout history and dividend yield track record.
INTEGFD Valuation Methods Summary — DCF, Graham Number & P/E
Integrated Proteins intrinsic value across 6 models vs current price ₹143.85 — upside/downside and value range per method. For current market price and key ratios, visit Integrated Proteins stock price NSE.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹43.15 | ₹34.52 - ₹51.78 | -70.0% | EPS: ₹0.12, Sector P/E: 12x |
| Book Value Method | asset | ₹28.77 | ₹25.89 - ₹31.65 | -80.0% | Book Value/Share: ₹11.05, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹43.15 | ₹38.84 - ₹47.47 | -70.0% | Revenue/Share: ₹5.26, P/S: 0.8x |
| PEG Ratio Method | growth | ₹43.15 | ₹38.84 - ₹47.47 | -70.0% | EPS Growth: 4.7%, Fair P/E: 3.7x |
| Growth Adjusted P/E | growth | ₹43.15 | ₹38.84 - ₹47.47 | -70.0% | Revenue Growth: 15.0%, Adj P/E: 8.6x |
| Graham Defensive Method | conservative | ₹43.15 | ₹38.84 - ₹47.47 | -70.0% | EPS: ₹0.12, BVPS: ₹11.05 |
INTEGFD Intrinsic Value vs Market Price — All Valuation Models
Integrated Proteins fair value range ₹29–₹43 vs current market price ₹143.85 across 6 valuation models. Analyse Integrated Proteins ownership structure to track promoter, FII and institutional holdings.
INTEGFD Intrinsic Value Analysis — Undervalued or Overvalued?
Integrated Proteins median intrinsic value ₹43.15, current price ₹143.85 — Trading Above Calculated Value by 70.0%, margin of safety -100.0%.
What is the intrinsic value of INTEGFD?
Based on our comprehensive analysis using 6 different valuation methods, the estimated intrinsic value of Integrated Proteins (INTEGFD) is ₹43.15 (median value). With the current market price of ₹143.85, this represents a -70.0% variance from our estimated fair value.
The valuation range spans from ₹28.77 to ₹43.15, indicating ₹28.77 - ₹43.15.
Is INTEGFD undervalued or overvalued?
Based on our multi-method analysis, Integrated Proteins (INTEGFD) appears to be trading above calculated value by approximately 70.0%.
INTEGFD Financial Health — Key Ratios vs Industry Benchmarks
Integrated Proteins financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Operating Margin | 3.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.48x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
INTEGFD Cash Flow Quality — Operating & Free Cash Flow
Integrated Proteins operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹-24 Cr | ₹-24 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2021 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |